Top Markets
#1 CoW Protocol CoW Protocol +62.99%
#2 EXOD EXOD +56.80%
#3 Glidr Glidr +38.25%
#4 Solv Protocol xSolvBTC Solv Protocol xSolvBTC +34.79%
#5 Walrus Walrus +26.86%
#6 Cysic Cysic +18.33%
#7 Humanity Humanity +17.83%
#8 Tutorial Tutorial +16.94%
#9 The Black Bull The Black Bull +16.75%
#10 Fabric Protocol Fabric Protocol +16.46%
Coin of the day
CoW Protocol CoW Protocol
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Relevium Technologies Inc. Relevium Technologies Inc.

Relevium Technologies Inc.

RLLVF
Rang in Aktien #37146
Relevium Technologies Inc. operates within the health and wellness sector,... Relevium Technologies Inc. operates within the health and wellness sector, focusing on identifying, assessing, acquiring, and managing various brands and businesses, primarily through e-commerce channels. The company distributes a range of products, including dietary supplements, nutraceuticals, sports nutrition items, and cosmeceuticals, mainly through its Bioganix online brand. It also offers dietary supplements under the LeefyLyfe label and skincare solutions marketed as the Push & Pull System. Additionally, Relevium has developed specialized lines such as Relevium Senior, aimed at older adults for inflammatory conditions affecting joints, heart, and brain, and Relevium Kids, providing nutraceuticals and oral nutritional supplements for children. Headquartered in Montreal, Canada, the company was formerly known as BIOflex Technologies Inc. until it rebranded to Relevium Technologies Inc. in December 2015.
Aktienkurs
$0.006
Zuletzt synchronisiert: 2026-08-13
Marktkapitalisierung
$1.98M
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
0.00%
Land
CA
Handel Relevium Technologies Inc. (RLLVF)

Kategorie

Healthcare
Gewinn für Relevium Technologies Inc. (RLLVF)
Gewinn im 2026 TTM: 0
Laut den aktuellen Finanzberichten von Relevium Technologies Inc. betragen die aktuellen Gewinne des Unternehmens 0. Im Jahr 2026 erzielte das Unternehmen einen Gewinn von 0, gleich wie dem Gewinn im Jahr 2026, der 0 betrug. Die auf dieser Seite angezeigten Gewinne sind die Gewinne vor Zinsen und Steuern, auch bekannt als EBIT.
Gewinnverlauf von Relevium Technologies Inc. von 2026 bis 2026
Gewinn am Ende jedes Jahres
Jahr Gewinn ändert
Nicht genügend Daten für die angegebenen Daten.
Gewinn ähnlicher Unternehmen oder Konkurrenten
Unternehmen Gewinn Gewinnunterschied Land
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
$1.35B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
- -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
- -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
- -
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
$26.37M -
US